Reduced caspase-2 protein levels have also been reported in a meta-analysis of published data sets for Burkitt lymphoma (BL), mantle cell lymphoma (MCL), chronic lymphocytic leukemia (CLL) and hairy cell leukemia [23, 25]. This evidence concerns the gene CASP2 and Burkitt lymphoma.